February 22, 2024

5:30-6:30 pm ET

Presenter: Alissa Visram MD MPH FRCPC
Division of Hematology, The Ottawa Hospital
Assistant Professor, University of Ottawa

Learning Objectives:

• Review practice changing updates in myeloma over the last year
• Discuss how updates apply within the Canadian context
• Review therapies that are on the horizon in Canada

Accreditation: This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists (CAP-AC). You may claim a maximum of 1.0 hours. Certificates of Attendance will be sent to all CHS members who participate.